Reversible Effects of Oral Contraceptive Removal on Serotonergic Neurotransmission

Clinical trial NCT07511439 · RECRUITING

Trial details

NCT number: NCT07511439
Sponsor: Rigshospitalet, Denmark
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

The Focus of the Study is to Investigate Reversible Effects of Combined Oral Contraceptive Use on Serotonergic Neurotransmission Healthy Adult Females

Start date: 2026-04-23
Primary completion: 2030-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.